| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein antigen binding | 2.94e-04 | 16 | 32 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 4.64e-04 | 20 | 32 | 2 | GO:0034185 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 1.32e-05 | 91 | 33 | 4 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.43e-05 | 93 | 33 | 4 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 1.63e-05 | 96 | 33 | 4 | GO:0050818 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 1.63e-05 | 31 | 33 | 3 | GO:1900048 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 1.63e-05 | 31 | 33 | 3 | GO:0030194 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 2.16e-05 | 34 | 33 | 3 | GO:0050820 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 2.47e-05 | 5 | 33 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | placenta blood vessel development | 4.73e-05 | 44 | 33 | 3 | GO:0060674 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 5.19e-05 | 7 | 33 | 2 | GO:0099183 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 6.91e-05 | 8 | 33 | 2 | GO:0099191 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.38e-04 | 166 | 33 | 4 | GO:0061041 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.82e-04 | 69 | 33 | 3 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.90e-04 | 70 | 33 | 3 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 2.06e-04 | 72 | 33 | 3 | GO:0050819 | |
| GeneOntologyBiologicalProcess | positive regulation of wound healing | 2.15e-04 | 73 | 33 | 3 | GO:0090303 | |
| GeneOntologyBiologicalProcess | negative regulation of fibrinolysis | 2.23e-04 | 14 | 33 | 2 | GO:0051918 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 2.31e-04 | 802 | 33 | 7 | GO:0048812 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.45e-04 | 566 | 33 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.62e-04 | 819 | 33 | 7 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.76e-04 | 826 | 33 | 7 | GO:0048858 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.09e-04 | 377 | 33 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 3.12e-04 | 1125 | 33 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.13e-04 | 378 | 33 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.17e-04 | 379 | 33 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 3.84e-04 | 217 | 33 | 4 | GO:1903034 | |
| GeneOntologyBiologicalProcess | trophoblast giant cell differentiation | 4.17e-04 | 19 | 33 | 2 | GO:0060707 | |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 4.17e-04 | 19 | 33 | 2 | GO:0051917 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 4.39e-04 | 93 | 33 | 3 | GO:1903036 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 4.66e-04 | 1194 | 33 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | axon development | 4.80e-04 | 642 | 33 | 6 | GO:0061564 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 5.12e-04 | 98 | 33 | 3 | GO:0061045 | |
| GeneOntologyBiologicalProcess | vasculature development | 7.22e-04 | 969 | 33 | 7 | GO:0001944 | |
| GeneOntologyBiologicalProcess | mononuclear cell migration | 7.36e-04 | 258 | 33 | 4 | GO:0071674 | |
| GeneOntologyBiologicalProcess | blood coagulation | 7.57e-04 | 260 | 33 | 4 | GO:0007596 | |
| GeneOntologyBiologicalProcess | neuron projection development | 7.59e-04 | 1285 | 33 | 8 | GO:0031175 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling, modulating synaptic transmission | 7.88e-04 | 26 | 33 | 2 | GO:0099550 | |
| GeneOntologyBiologicalProcess | coagulation | 8.24e-04 | 266 | 33 | 4 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 8.48e-04 | 268 | 33 | 4 | GO:0007599 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 9.81e-04 | 29 | 33 | 2 | GO:0042730 | |
| GeneOntologyBiologicalProcess | labyrinthine layer blood vessel development | 9.81e-04 | 29 | 33 | 2 | GO:0060716 | |
| GeneOntologyBiologicalProcess | wound healing | 1.04e-03 | 493 | 33 | 5 | GO:0042060 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.06e-03 | 126 | 33 | 3 | GO:1903035 | |
| GeneOntologyBiologicalProcess | protein processing | 1.07e-03 | 285 | 33 | 4 | GO:0016485 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.07e-03 | 748 | 33 | 6 | GO:0048667 | |
| GeneOntologyBiologicalProcess | muscle cell cellular homeostasis | 1.12e-03 | 31 | 33 | 2 | GO:0046716 | |
| GeneOntologyBiologicalProcess | tube development | 1.34e-03 | 1402 | 33 | 8 | GO:0035295 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in embryonic placenta development | 1.35e-03 | 34 | 33 | 2 | GO:0060706 | |
| GeneOntologyBiologicalProcess | embryo development | 1.57e-03 | 1437 | 33 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.68e-03 | 817 | 33 | 6 | GO:0048514 | |
| GeneOntologyBiologicalProcess | neuron development | 1.76e-03 | 1463 | 33 | 8 | GO:0048666 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 1.92e-03 | 1483 | 33 | 8 | GO:0048646 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.05e-03 | 42 | 33 | 2 | GO:0090330 | |
| GeneOntologyBiologicalProcess | muscle structure development | 2.15e-03 | 858 | 33 | 6 | GO:0061061 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.60e-04 | 530 | 33 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 3.24e-04 | 17 | 33 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.01e-04 | 656 | 33 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.10e-04 | 658 | 33 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 7.65e-04 | 114 | 33 | 3 | GO:0005798 | |
| GeneOntologyCellularComponent | cell surface | 1.49e-03 | 1111 | 33 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | mediator complex | 1.55e-03 | 37 | 33 | 2 | GO:0016592 | |
| GeneOntologyCellularComponent | receptor complex | 2.03e-03 | 581 | 33 | 5 | GO:0043235 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 3.87e-06 | 2 | 28 | 2 | MP:0009507 | |
| MousePheno | esophageal ulcer | 3.87e-06 | 2 | 28 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 3.87e-06 | 2 | 28 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 3.87e-06 | 2 | 28 | 2 | MP:0005035 | |
| MousePheno | ectropion | 3.87e-06 | 2 | 28 | 2 | MP:0006164 | |
| MousePheno | absent cornea epithelium | 1.16e-05 | 3 | 28 | 2 | MP:0020856 | |
| MousePheno | increased circulating fibrinogen level | 2.32e-05 | 4 | 28 | 2 | MP:0012331 | |
| MousePheno | proctitis | 2.32e-05 | 4 | 28 | 2 | MP:0003305 | |
| MousePheno | gastric ulcer | 5.77e-05 | 6 | 28 | 2 | MP:0003282 | |
| MousePheno | increased acute phase protein level | 8.07e-05 | 7 | 28 | 2 | MP:0014499 | |
| MousePheno | abnormal conjunctival epithelium morphology | 8.07e-05 | 7 | 28 | 2 | MP:0004481 | |
| MousePheno | venoocclusion | 8.07e-05 | 7 | 28 | 2 | MP:0006137 | |
| MousePheno | peptic ulcer | 8.07e-05 | 7 | 28 | 2 | MP:0003301 | |
| MousePheno | decreased keratinocyte migration | 1.08e-04 | 8 | 28 | 2 | MP:0012194 | |
| MousePheno | abnormal circulating fibrinogen level | 1.08e-04 | 8 | 28 | 2 | MP:0010213 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 1.72e-04 | 10 | 28 | 2 | MP:0003434 | |
| MousePheno | abnormal kidney thrombosis | 1.72e-04 | 10 | 28 | 2 | MP:0011507 | |
| MousePheno | abnormal keratinocyte migration | 2.10e-04 | 11 | 28 | 2 | MP:0012192 | |
| MousePheno | abnormal anus morphology | 2.98e-04 | 13 | 28 | 2 | MP:0005034 | |
| MousePheno | abnormal conjunctiva morphology | 2.98e-04 | 13 | 28 | 2 | MP:0001310 | |
| MousePheno | abnormal chorion morphology | 4.24e-04 | 74 | 28 | 3 | MP:0002836 | |
| MousePheno | increased hepatocyte proliferation | 5.16e-04 | 17 | 28 | 2 | MP:0003893 | |
| MousePheno | lactation failure | 5.16e-04 | 17 | 28 | 2 | MP:0010249 | |
| MousePheno | choroidal neovascularization | 6.48e-04 | 19 | 28 | 2 | MP:0005546 | |
| MousePheno | abnormal involution of the mammary gland | 1.04e-03 | 24 | 28 | 2 | MP:0006271 | |
| MousePheno | intestinal ulcer | 1.04e-03 | 24 | 28 | 2 | MP:0000512 | |
| MousePheno | decreased pulmonary respiratory rate | 1.13e-03 | 25 | 28 | 2 | MP:0005574 | |
| MousePheno | abnormal acute phase protein level | 1.13e-03 | 25 | 28 | 2 | MP:0010211 | |
| MousePheno | conjunctivitis | 1.22e-03 | 26 | 28 | 2 | MP:0001852 | |
| MousePheno | abnormal eye vasculature morphology | 1.26e-03 | 415 | 28 | 5 | MP:0031346 | |
| MousePheno | abnormal choroid vasculature morphology | 1.32e-03 | 27 | 28 | 2 | MP:0006237 | |
| MousePheno | abnormal anal canal morphology | 1.32e-03 | 27 | 28 | 2 | MP:0009053 | |
| MousePheno | abnormal mammary gland growth during lactation | 1.42e-03 | 28 | 28 | 2 | MP:0006270 | |
| MousePheno | rectal prolapse | 1.52e-03 | 29 | 28 | 2 | MP:0000493 | |
| Domain | Kringle | 3.06e-06 | 17 | 32 | 3 | IPR000001 | |
| Domain | Kringle_CS | 3.06e-06 | 17 | 32 | 3 | IPR018056 | |
| Domain | KRINGLE_2 | 3.06e-06 | 17 | 32 | 3 | PS50070 | |
| Domain | Kringle | 3.06e-06 | 17 | 32 | 3 | PF00051 | |
| Domain | KRINGLE_1 | 3.06e-06 | 17 | 32 | 3 | PS00021 | |
| Domain | KR | 3.06e-06 | 17 | 32 | 3 | SM00130 | |
| Domain | EGF_1 | 4.11e-06 | 255 | 32 | 6 | PS00022 | |
| Domain | EGF_2 | 5.13e-06 | 265 | 32 | 6 | PS01186 | |
| Domain | Kringle-like | 2.19e-05 | 32 | 32 | 3 | IPR013806 | |
| Domain | ConA-like_dom | 3.29e-05 | 219 | 32 | 5 | IPR013320 | |
| Domain | EGF | 4.61e-05 | 235 | 32 | 5 | SM00181 | |
| Domain | EGF-like_dom | 6.07e-05 | 249 | 32 | 5 | IPR000742 | |
| Domain | EGF | 6.13e-05 | 126 | 32 | 4 | PF00008 | |
| Domain | EGF-like_CS | 7.58e-05 | 261 | 32 | 5 | IPR013032 | |
| Domain | TSP_1 | 1.69e-04 | 63 | 32 | 3 | PF00090 | |
| Domain | TSP1 | 1.86e-04 | 65 | 32 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.86e-04 | 65 | 32 | 3 | IPR000884 | |
| Domain | TSP1 | 1.86e-04 | 65 | 32 | 3 | PS50092 | |
| Domain | MAM_1 | 3.36e-04 | 16 | 32 | 2 | PS00740 | |
| Domain | MAM | 3.81e-04 | 17 | 32 | 2 | SM00137 | |
| Domain | MAM | 4.28e-04 | 18 | 32 | 2 | PF00629 | |
| Domain | MAM_dom | 4.28e-04 | 18 | 32 | 2 | IPR000998 | |
| Domain | MAM_2 | 4.28e-04 | 18 | 32 | 2 | PS50060 | |
| Domain | Rho_GTPase_activation_prot | 4.54e-04 | 88 | 32 | 3 | IPR008936 | |
| Domain | EGF_3 | 6.66e-04 | 235 | 32 | 4 | PS50026 | |
| Domain | EGF_LAM_2 | 1.20e-03 | 30 | 32 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.20e-03 | 30 | 32 | 2 | PS01248 | |
| Domain | Sema | 1.28e-03 | 31 | 32 | 2 | SM00630 | |
| Domain | Semap_dom | 1.28e-03 | 31 | 32 | 2 | IPR001627 | |
| Domain | Sema | 1.28e-03 | 31 | 32 | 2 | PF01403 | |
| Domain | SEMA | 1.28e-03 | 31 | 32 | 2 | PS51004 | |
| Domain | PSI | 1.37e-03 | 32 | 32 | 2 | PF01437 | |
| Domain | Plexin_repeat | 1.37e-03 | 32 | 32 | 2 | IPR002165 | |
| Domain | Laminin_EGF | 1.63e-03 | 35 | 32 | 2 | PF00053 | |
| Domain | EGF_Lam | 1.63e-03 | 35 | 32 | 2 | SM00180 | |
| Domain | LAM_G_DOMAIN | 1.92e-03 | 38 | 32 | 2 | PS50025 | |
| Domain | Laminin_EGF | 1.92e-03 | 38 | 32 | 2 | IPR002049 | |
| Domain | Laminin_G_2 | 2.13e-03 | 40 | 32 | 2 | PF02210 | |
| Domain | Growth_fac_rcpt_ | 2.37e-03 | 156 | 32 | 3 | IPR009030 | |
| Domain | PSI | 2.57e-03 | 44 | 32 | 2 | IPR016201 | |
| Domain | LamG | 2.57e-03 | 44 | 32 | 2 | SM00282 | |
| Domain | PSI | 2.81e-03 | 46 | 32 | 2 | SM00423 | |
| Domain | CUB | 3.18e-03 | 49 | 32 | 2 | PF00431 | |
| Domain | CUB | 3.31e-03 | 50 | 32 | 2 | SM00042 | |
| Domain | - | 3.57e-03 | 52 | 32 | 2 | 2.60.120.290 | |
| Domain | CUB | 3.71e-03 | 53 | 32 | 2 | PS01180 | |
| Domain | Ig_I-set | 4.14e-03 | 190 | 32 | 3 | IPR013098 | |
| Domain | I-set | 4.14e-03 | 190 | 32 | 3 | PF07679 | |
| Domain | CUB_dom | 4.28e-03 | 57 | 32 | 2 | IPR000859 | |
| Domain | Laminin_G | 4.43e-03 | 58 | 32 | 2 | IPR001791 | |
| Domain | RhoGAP | 5.04e-03 | 62 | 32 | 2 | SM00324 | |
| Domain | RhoGAP | 5.20e-03 | 63 | 32 | 2 | PF00620 | |
| Domain | RHOGAP | 5.37e-03 | 64 | 32 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 5.37e-03 | 64 | 32 | 2 | IPR000198 | |
| Domain | - | 5.37e-03 | 64 | 32 | 2 | 1.10.555.10 | |
| Domain | IGc2 | 7.45e-03 | 235 | 32 | 3 | SM00408 | |
| Domain | Ig_sub2 | 7.45e-03 | 235 | 32 | 3 | IPR003598 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.83e-06 | 68 | 26 | 4 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.87e-05 | 39 | 26 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.87e-05 | 39 | 26 | 3 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 8.17e-05 | 250 | 26 | 5 | M27554 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.28e-04 | 143 | 26 | 4 | M27275 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 2.13e-04 | 12 | 26 | 2 | MM1398 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.94e-04 | 14 | 26 | 2 | MM1458 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 3.38e-04 | 15 | 26 | 2 | MM15450 | |
| Pathway | WP_BDNF_PATHWAY | 3.86e-04 | 16 | 26 | 2 | MM15816 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 8.08e-04 | 23 | 26 | 2 | MM15936 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.03e-03 | 109 | 26 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.08e-03 | 111 | 26 | 3 | M27416 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 1.57e-03 | 32 | 26 | 2 | M165 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.67e-03 | 129 | 26 | 3 | M5539 | |
| Pubmed | 1.35e-08 | 167 | 34 | 6 | 22159717 | ||
| Pubmed | 1.78e-08 | 175 | 34 | 6 | 28071719 | ||
| Pubmed | 8.81e-07 | 75 | 34 | 4 | 20637190 | ||
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 9.28e-07 | 2 | 34 | 2 | 21239499 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31690812 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30254165 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10642175 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12225871 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9770530 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 9.28e-07 | 2 | 34 | 2 | 9819364 | |
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 9.28e-07 | 2 | 34 | 2 | 30323258 | |
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 9.28e-07 | 2 | 34 | 2 | 37971174 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9884337 | ||
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 9.28e-07 | 2 | 34 | 2 | 10634603 | |
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 9.28e-07 | 2 | 34 | 2 | 26473342 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 9.28e-07 | 2 | 34 | 2 | 23943648 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 9.28e-07 | 2 | 34 | 2 | 18420257 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 9.28e-07 | 2 | 34 | 2 | 7705657 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10816371 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23041318 | ||
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 9.28e-07 | 2 | 34 | 2 | 18566672 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19752236 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 9.28e-07 | 2 | 34 | 2 | 26791370 | |
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 9.28e-07 | 2 | 34 | 2 | 32694536 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 7525077 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 6216475 | ||
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 9.28e-07 | 2 | 34 | 2 | 16052596 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17122079 | ||
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 9.28e-07 | 2 | 34 | 2 | 20653841 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12428098 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 9.28e-07 | 2 | 34 | 2 | 20440070 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16103174 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24732409 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21300353 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 9.28e-07 | 2 | 34 | 2 | 15456492 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 9.28e-07 | 2 | 34 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 9.28e-07 | 2 | 34 | 2 | 16956791 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 25409527 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15737740 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11306011 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 1543918 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12149246 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 8704243 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22056679 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17267741 | ||
| Pubmed | Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. | 9.28e-07 | 2 | 34 | 2 | 18311818 | |
| Pubmed | Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. | 9.28e-07 | 2 | 34 | 2 | 21190118 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18039665 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9671388 | ||
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 9.28e-07 | 2 | 34 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 9.28e-07 | 2 | 34 | 2 | 10885855 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23702659 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29990619 | ||
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 9.28e-07 | 2 | 34 | 2 | 12559391 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17293777 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 27319402 | ||
| Pubmed | Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. | 9.28e-07 | 2 | 34 | 2 | 15333838 | |
| Pubmed | Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. | 9.28e-07 | 2 | 34 | 2 | 16150044 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11916082 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 9.28e-07 | 2 | 34 | 2 | 10854210 | |
| Pubmed | Unaltered prion protein cleavage in plasminogen-deficient mice. | 9.28e-07 | 2 | 34 | 2 | 16543819 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34423816 | ||
| Pubmed | Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. | 9.28e-07 | 2 | 34 | 2 | 11500461 | |
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 9.28e-07 | 2 | 34 | 2 | 23527289 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 9.28e-07 | 2 | 34 | 2 | 22079981 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12167431 | ||
| Pubmed | Impaired wound healing in mice with a disrupted plasminogen gene. | 9.28e-07 | 2 | 34 | 2 | 8612226 | |
| Pubmed | Role of plasminogen activation in neuronal organization and survival. | 9.28e-07 | 2 | 34 | 2 | 19683575 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 9.28e-07 | 2 | 34 | 2 | 9490683 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10537128 | ||
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 9.28e-07 | 2 | 34 | 2 | 23555246 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16481742 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18983515 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18685433 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31462325 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34378815 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 9.28e-07 | 2 | 34 | 2 | 7586361 | |
| Pubmed | Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. | 9.28e-07 | 2 | 34 | 2 | 9242524 | |
| Pubmed | Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling. | 9.62e-07 | 20 | 34 | 3 | 20133625 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 16818777 | ||
| Pubmed | Skin wound healing in MMP2-deficient and MMP2 / plasminogen double-deficient mice. | 2.78e-06 | 3 | 34 | 2 | 20163454 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 19273908 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 9473227 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 17988229 | ||
| Pubmed | Genetic background determines response to hemostasis and thrombosis. | 2.78e-06 | 3 | 34 | 2 | 17022820 | |
| Pubmed | Plasminogen binds to disease-associated prion protein of multiple species. | 2.78e-06 | 3 | 34 | 2 | 11438139 | |
| Pubmed | Lactational competence and involution of the mouse mammary gland require plasminogen. | 2.78e-06 | 3 | 34 | 2 | 11003846 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 15099286 | ||
| Pubmed | Pneumococcal phosphoglycerate kinase interacts with plasminogen and its tissue activator. | 2.78e-06 | 3 | 34 | 2 | 24196407 | |
| Pubmed | Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice. | 2.78e-06 | 3 | 34 | 2 | 15364412 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 28320709 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 17722076 | ||
| Pubmed | Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. | 2.78e-06 | 3 | 34 | 2 | 21940822 | |
| Pubmed | Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. | 2.78e-06 | 3 | 34 | 2 | 26214526 | |
| Pubmed | Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. | 2.78e-06 | 3 | 34 | 2 | 12431907 | |
| Interaction | FBN2 interactions | 3.76e-06 | 65 | 33 | 4 | int:FBN2 | |
| Interaction | MEP1A interactions | 7.91e-06 | 24 | 33 | 3 | int:MEP1A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 6.35e-05 | 16 | 34 | 2 | chr6q26 | |
| Cytoband | 6q26 | 8.08e-05 | 18 | 34 | 2 | 6q26 | |
| Cytoband | 22q13.33 | 3.68e-04 | 38 | 34 | 2 | 22q13.33 | |
| Cytoband | 11p15.4 | 9.67e-03 | 200 | 34 | 2 | 11p15.4 | |
| GeneFamily | Cyclins|Mediator complex | 7.98e-04 | 33 | 23 | 2 | 1061 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.08e-03 | 161 | 23 | 3 | 593 | |
| Coexpression | NABA_MATRISOME | MEP1A NTN5 ADAMTSL1 CLEC9A PLG SEMA5B PLXNB2 EMILIN1 LPA LAMA1 | 3.82e-07 | 1008 | 34 | 10 | MM17056 |
| Coexpression | NABA_MATRISOME | MEP1A NTN5 ADAMTSL1 CLEC9A PLG SEMA5B PLXNB2 EMILIN1 LPA LAMA1 | 4.50e-07 | 1026 | 34 | 10 | M5889 |
| Coexpression | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP | 2.44e-05 | 6 | 34 | 2 | MM555 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.78e-05 | 738 | 34 | 7 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 4.22e-05 | 751 | 34 | 7 | M5885 | |
| Coexpression | MIKKELSEN_IPS_LCP_WITH_H3K4ME3 | 7.61e-05 | 175 | 34 | 4 | M1975 | |
| Coexpression | MIKKELSEN_IPS_LCP_WITH_H3K4ME3 | 8.31e-05 | 179 | 34 | 4 | MM845 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 184 | 34 | 4 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 121 | 34 | 3 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | (03)_Secretory-(1)_24hpi|(03)_Secretory / shred by cell type and Timepoint | 1.48e-04 | 135 | 34 | 3 | 6e473296dfe1ff7a63d701e56920c0a1b043ddc6 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-04 | 142 | 34 | 3 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 153 | 34 | 3 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 153 | 34 | 3 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 153 | 34 | 3 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.39e-04 | 159 | 34 | 3 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 167 | 34 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-04 | 167 | 34 | 3 | 7cb5b52aaa5b595fe2e97d9e175294ea8d63b165 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-04 | 168 | 34 | 3 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 169 | 34 | 3 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 170 | 34 | 3 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 171 | 34 | 3 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-04 | 171 | 34 | 3 | 1018d7bd378ce20bee56a77d5851b3538c55098c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 171 | 34 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 171 | 34 | 3 | 0417fa805ca0acb7e9f6a30bc7b6bdbaba77844d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-04 | 171 | 34 | 3 | 173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-04 | 171 | 34 | 3 | 6bda333bb751d7835a04f21ac959eea79f2516aa | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 171 | 34 | 3 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 176 | 34 | 3 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.22e-04 | 176 | 34 | 3 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 176 | 34 | 3 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 177 | 34 | 3 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.33e-04 | 178 | 34 | 3 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.44e-04 | 180 | 34 | 3 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 181 | 34 | 3 | bec917f6f56ae252639a5a76024be5df5c70a6d5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-04 | 182 | 34 | 3 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-04 | 182 | 34 | 3 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-04 | 182 | 34 | 3 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-04 | 183 | 34 | 3 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.67e-04 | 184 | 34 | 3 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-04 | 186 | 34 | 3 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.79e-04 | 186 | 34 | 3 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.85e-04 | 187 | 34 | 3 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.85e-04 | 187 | 34 | 3 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.97e-04 | 189 | 34 | 3 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.09e-04 | 191 | 34 | 3 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 192 | 34 | 3 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 192 | 34 | 3 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 192 | 34 | 3 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 192 | 34 | 3 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.22e-04 | 193 | 34 | 3 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-04 | 193 | 34 | 3 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.22e-04 | 193 | 34 | 3 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.28e-04 | 194 | 34 | 3 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.28e-04 | 194 | 34 | 3 | fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.35e-04 | 195 | 34 | 3 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.35e-04 | 195 | 34 | 3 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 195 | 34 | 3 | d663d54a4bcc94e2c9b50ed931e2b2db4ca41373 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.35e-04 | 195 | 34 | 3 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.35e-04 | 195 | 34 | 3 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.35e-04 | 195 | 34 | 3 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.41e-04 | 196 | 34 | 3 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.41e-04 | 196 | 34 | 3 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 196 | 34 | 3 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 196 | 34 | 3 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 4.48e-04 | 197 | 34 | 3 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.48e-04 | 197 | 34 | 3 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 4.48e-04 | 197 | 34 | 3 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-04 | 197 | 34 | 3 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-04 | 197 | 34 | 3 | a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 197 | 34 | 3 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.54e-04 | 198 | 34 | 3 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Transverse-T_cell-Tcm|T_cell / Region, Cell class and subclass | 4.54e-04 | 198 | 34 | 3 | 62990b9ff7ca20895fed07461baba6c2caaa995e | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 4.61e-04 | 199 | 34 | 3 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 4.61e-04 | 199 | 34 | 3 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.61e-04 | 199 | 34 | 3 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 199 | 34 | 3 | 83383d9ae4f501754fd3da0215ce6f0e3c70562c | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.61e-04 | 199 | 34 | 3 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.61e-04 | 199 | 34 | 3 | 7271dbeca9aa838b88ad44d00059263a29c0316b | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 199 | 34 | 3 | 01d101b0fd5326947a9e5dddae6c2f93ab6e0a4d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 199 | 34 | 3 | f26c20f5d7470e90eaa79613d0b87bd4865585a8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 199 | 34 | 3 | a10768e1cddd2d38291c30d24820a94040a72211 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-04 | 199 | 34 | 3 | 6d439c0c5e6b72fcb8d4dc72e7445eb6a01fe095 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-04 | 200 | 34 | 3 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 4.68e-04 | 200 | 34 | 3 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| Drug | Aminocaproic Acid | 5.74e-06 | 3 | 32 | 2 | DB00513 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 1.29e-05 | 5 | 34 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | plasma plasminogen measurement | 1.29e-05 | 5 | 34 | 2 | EFO_0006309 | |
| Disease | angiostatin measurement | 1.93e-05 | 6 | 34 | 2 | EFO_0008024 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 2.70e-05 | 7 | 34 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | albuminuria | 1.74e-04 | 94 | 34 | 3 | EFO_0004285 | |
| Disease | Deep Vein Thrombosis | 2.67e-04 | 21 | 34 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 2.67e-04 | 21 | 34 | 2 | C0042487 | |
| Disease | arginine measurement | 3.21e-04 | 23 | 34 | 2 | EFO_0020990 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 4.12e-04 | 26 | 34 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | blood manganese measurement | 4.44e-04 | 27 | 34 | 2 | EFO_0007581 | |
| Disease | colorectal cancer (implicated_via_orthology) | 5.49e-04 | 30 | 34 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 6.65e-04 | 33 | 34 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.06e-04 | 34 | 34 | 2 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.06e-04 | 34 | 34 | 2 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 8.37e-04 | 37 | 34 | 2 | EFO_0022252 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 9.78e-04 | 40 | 34 | 2 | EFO_0004746 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.08e-03 | 42 | 34 | 2 | EFO_0022255 | |
| Disease | Charcot-Marie-Tooth disease | 1.08e-03 | 42 | 34 | 2 | cv:C0007959 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.08e-03 | 42 | 34 | 2 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.13e-03 | 43 | 34 | 2 | EFO_0022290 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLPVPSNQCCNWNYF | 166 | Q9UPW8 | |
| AVRPGPCWAPNYCSF | 801 | Q6UXC1 | |
| PCCPPQYNVVQLWAH | 296 | Q86VI1 | |
| PALYCNCDADQPQWR | 726 | P78357 | |
| CVQLNNRFFWQPDPP | 1431 | Q96PZ7 | |
| INRNWNYPFPRCDAP | 2131 | Q96PZ7 | |
| PCPACPFVQAQWSRQ | 161 | Q96M86 | |
| VDGVNTYNCRCPPQW | 276 | Q04721 | |
| TYNCRCPPQWTGQFC | 281 | Q04721 | |
| CSSPLPCWDYINNQC | 1466 | Q04721 | |
| FLNWPAYQKCRQPDC | 171 | A6NDA9 | |
| QACNRFNCPPAWYPA | 721 | Q8N6G6 | |
| FNCPPAWYPAQWQPC | 726 | Q8N6G6 | |
| DQVYRGQPCSCWPRP | 1496 | O15031 | |
| PFPNCDWRFNEFPNP | 1086 | Q9ULK4 | |
| VLPQWLCSNCQAPYD | 2181 | Q07864 | |
| VWPCYDSCPRAQPDA | 1636 | O95248 | |
| SPNFPNNYPNNWECI | 1061 | O60494 | |
| KNYCRNPDPVAAPWC | 986 | P08519 | |
| KYQPCAWGQPQCPQS | 81 | Q9Y6C2 | |
| RQFNCSPHPYWLPNF | 341 | P16298 | |
| CPCDKYNAQPVGNWS | 956 | Q9UPZ6 | |
| CHYCQPGFWRDPSQP | 251 | Q8WTR8 | |
| NLNRYCQEHWPFQPC | 101 | A0A1B0GUV7 | |
| CNRCCPGYHQQPWRP | 301 | P25391 | |
| WPQYFRDPCDPNPCQ | 666 | Q16819 | |
| FWSACPQAQYQCPLF | 2081 | Q9UHV7 | |
| YCRNPDNDPQGPWCY | 151 | P00747 | |
| WLNCDPNPPDIYCIG | 261 | Q01968 | |
| PNRFCADCGAPQPDW | 546 | Q96P48 | |
| SPCPNNWIQNRESCY | 111 | Q6UXN8 | |
| TCQPPQFQLLWLCPY | 191 | Q8NBR9 | |
| YCRNPGNQKEAPWCF | 361 | Q01973 | |
| QNWGYTCPLCRAPVQ | 51 | Q6AZZ1 | |
| RFCNENTPCPVPIFW | 711 | Q9P283 | |
| WWRCNGPCQHRPPYY | 166 | Q9H040 | |
| NARPDNWFCYPCIPN | 266 | Q15326 | |
| FYAPWCPACQNLQPE | 51 | Q9H3N1 |